dalteparin has been researched along with fluorobenzenes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, YJ; Han, SJ; Jo, SH; Kim, HS; Kim, SA; Park, WJ; Rhim, CY | 1 |
1 trial(s) available for dalteparin and fluorobenzenes
Article | Year |
---|---|
Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.
Topics: Arthroplasty, Replacement, Knee; Drug Therapy, Combination; Enoxaparin; Fluorobenzenes; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Orthopedic Procedures; Pyrimidines; Research Design; Risk Assessment; Rosuvastatin Calcium; Sample Size; Sulfonamides; Venous Thrombosis | 2011 |